Tool Predicted Vedolizumab Nonresponse in Routine Practice Tool Predicted Vedolizumab Nonresponse in Routine Practice

Among patients with ulcerative colitis who were treated in routine practice, a point-based clinical scoring tool predicted nonresponse to vedolizumab therapy.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Gastroenterology News Source Type: news